WallStreetZenWallStreetZen

NASDAQ: RDGT
Ridgetech Inc Stock

Overview
EarningsRevenueDividendOwnership
$0.95-0.04 (-4.04%)
Updated Apr 24, 2025
RDGT Price
$0.95
Fair Value Price
N/A
Market Cap
$6.32M
52 Week Low
$0.72
52 Week High
$4.50
P/E
-0.37x
P/B
0.29x
P/S
0.08x
PEG
N/A
Dividend Yield
N/A
Revenue
$147.13M
Earnings
-$5.59M
Gross Margin
20.2%
Operating Margin
-3.76%
Profit Margin
-3.8%
Debt to Equity
3.45
Operating Cash Flow
-$14M
Beta
0.91
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

RDGT Overview

Ridgetech Inc operates as a holding company. The Company, through its subsidiaries, wholesales, distributes, and retails pharmaceutical and other healthcare products.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine RDGT's potential to beat the market

View All “A” Zen Rated Stocks
→

Zen Rating Component Grades

N/A
Value
N/A
Growth
N/A
Momentum
N/A
Sentiment
N/A
Safety
N/A
Financials
N/A
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Pharmaceutical Retailer

Industry Rating
D
RDGT
RankedUnranked of 4

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
111 (YI)
$8.53C
High Tide (HITI)
$2.38C
Wellgistics Health (WGRX)
$4.27C
View Top Pharmaceutical Retailer Stocks

Be the first to know about important RDGT news, forecast changes, insider trades & much more!

RDGT News

Overview

Due Diligence Score

–
Industry Average (25)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how RDGT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

RDGT is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
RDGT is good value based on its book value relative to its share price (0.29x), compared to the US Pharmaceutical Retailers industry average (1.37x)
P/B vs Industry Valuation
RDGT is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more RDGT due diligence checks available for Premium users.

Valuation

RDGT price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-0.37x
Industry
-0.29x
Market
26.39x

RDGT price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
0.29x
Industry
1.37x
RDGT is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

RDGT's financial health

Profit margin

Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
RDGT's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
RDGT's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$94.2M
Liabilities
$74.1M
Debt to equity
3.45
RDGT's short-term assets ($71.08M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
RDGT's short-term assets ($71.08M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
RDGT's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
RDGT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
N/A
Investing
N/A
Financing
N/A
RDGT's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

RDGT vs Pharmaceutical Retailer Stocks

TickerZen RatingMarket Cap1d %P/EP/B
RDGT–$6.32M-4.04%-0.37x0.29x
SSY–$6.20M-2.22%6.29x0.44x
SCNX–$11.89M+8.20%0.35x0.15x
PETSC$72.71M+4.45%352.00x0.76x
YIC$73.68M+1.31%N/A-0.85x
View Top Pharmaceutical Retailer Stocks

Ridgetech Stock FAQ

What is Ridgetech's quote symbol?

(NASDAQ: RDGT) Ridgetech trades on the NASDAQ under the ticker symbol RDGT. Ridgetech stock quotes can also be displayed as NASDAQ: RDGT.

If you're new to stock investing, here's how to buy Ridgetech stock.

What is the 52 week high and low for Ridgetech (NASDAQ: RDGT)?

(NASDAQ: RDGT) Ridgetech's 52-week high was $4.50, and its 52-week low was $0.72. It is currently -78.89% from its 52-week high and 31.94% from its 52-week low.

How much is Ridgetech stock worth today?

(NASDAQ: RDGT) Ridgetech currently has 6,654,077 outstanding shares. With Ridgetech stock trading at $0.95 per share, the total value of Ridgetech stock (market capitalization) is $6.32M.

Ridgetech stock was originally listed at a price of $3.54 in Oct 1, 2009. If you had invested in Ridgetech stock at $3.54, your return over the last 15 years would have been -73.16%, for an annualized return of -8.4% (not including any dividends or dividend reinvestments).

How much is Ridgetech's stock price per share?

(NASDAQ: RDGT) Ridgetech stock price per share is $0.95 today (as of Apr 24, 2025).

What is Ridgetech's Market Cap?

(NASDAQ: RDGT) Ridgetech's market cap is $6.32M, as of Apr 26, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Ridgetech's market cap is calculated by multiplying RDGT's current stock price of $0.95 by RDGT's total outstanding shares of 6,654,077.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.